Association Between Heart Failure With Preserved Left Ventricular Ejection Fraction and Impaired Left Atrial Phasic

Rui Shi1, Ke Shi1, Shan Huang1

  • 1Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.

Insights

Left atrial (LA) phasic function is significantly impaired in hypertrophic cardiomyopathy (HCM) patients with heart failure with preserved ejection fraction (HFpEF). This impairment is independent of left ventricular (LV) global longitudinal strain.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Biomedical Engineering

Background:

  • Heart failure (HF) in hypertrophic cardiomyopathy (HCM) often presents as preserved left ventricular (LV) ejection fraction (HFpEF).
  • The specific role of left atrial (LA) phasic function in the development of HFpEF within HCM patients remains unclear.

Purpose of the Study:

  • To investigate the association between LA phasic function and HFpEF in HCM patients.
  • To utilize cardiac magnetic resonance imaging (MRI) feature tracking for this assessment.

Main Methods:

  • Retrospective study of 154 HCM patients, categorized into HFpEF and non-HF groups.
  • Cardiac MRI with feature tracking to evaluate LA reservoir, conduit, and booster pump functions, alongside LV global longitudinal strain (GLS).
  • Statistical analyses included regression and reclassification models to determine independent associations.

Main Results:

  • No significant difference in LV GLS was observed between HFpEF and non-HF groups.
  • Patients with HFpEF exhibited significantly impaired LA reservoir, conduit, and booster pump strain.
  • LA reservoir and booster pump strain were independently associated with HFpEF and improved reclassification models.

Conclusions:

  • Left atrial phasic function is severely compromised in HCM patients with HFpEF.
  • LA function, particularly reservoir and booster pump function, plays a critical role in HFpEF in HCM, independent of LV function.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
93
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
44
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
100
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
76
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
79